CentrosHealth will now Capture Medical Device Data
According to the release, PPD noted that wearable technology will have the potential to benefit Novartis and its other clients because of the integration with the technologies patients use on a daily basis.
Clinical Ink, a provider of eSource solutions for clinical trials, announced that CentrosHealth, a mobile patient engagement platform, now includes streamlined connectivity for a wide range of medical devices. This new platform was developed with cooperation from Novartis and PPD, who are also supporting a pilot clinical study before broad commercial use. According to the release, PPD noted that wearable technology will have the potential to benefit Novartis and its other clients because of the integration with the technologies patients use on a daily basis. Read the full release here.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
